Cleavage of vimentin by different retroviral proteases.

Proteases (PRs) of retroviruses cleave viral polyproteins into their mature structural proteins and replication enzymes. Besides this essential role in the replication cycle of retroviruses, PRs also cleave a variety of host cell proteins. We have analyzed the in vitro cleavage of mouse vimentin by proteases of human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2), bovine leukemia virus (BLV), Mason-Pfizer monkey virus (M-PMV), myeloblastosis-associated virus (MAV), and two active-site mutants of MAV PR. Retroviral proteases display significant differences in specificity requirements. Here, we show a comparison of substrate specificities of several retroviral proteases on vimentin as a substrate. Vimentin was cleaved by all the proteases at different sites and with different rates. The results show that the physiologically important cellular protein vimentin can be degraded by different retroviral proteases.

[1]  Y. Capetanaki,et al.  Desmin in muscle formation and maintenance: knockouts and consequences. , 1997, Cell structure and function.

[2]  J. Konvalinka,et al.  High‐level expression of enzymatically active bovine leukemia virus proteinase in E. coli , 1991, FEBS letters.

[3]  R. Shoeman,et al.  Cleavage of human and mouse cytoskeletal and sarcomeric proteins by human immunodeficiency virus type 1 protease. Actin, desmin, myosin, and tropomyosin. , 1993, The American journal of pathology.

[4]  E. Fuchs.  Keith R. Porter Lecture, 1996. Of mice and men: genetic disorders of the cytoskeleton. , 1997, Molecular biology of the cell.

[5]  R. Shoeman,et al.  Non‐viral cellular substrates for human immunodeficiency virus type 1 protease , 1991, FEBS letters.

[6]  R. Shoeman,et al.  Characterization of the nucleic acid binding region of the intermediate filament protein vimentin by fluorescence polarization. , 1999, Biochemistry.

[7]  A. Tomasselli,et al.  Actin, troponin C, Alzheimer amyloid precursor protein and pro-interleukin 1 beta as substrates of the protease from human immunodeficiency virus. , 1991, The Journal of biological chemistry.

[8]  M. A. McClure,et al.  Origins and Evolutionary Relationships of Retroviruses , 1989, The Quarterly Review of Biology.

[9]  J. Konvalinka,et al.  Proteolytic processing of particle-associated retroviral polyproteins by homologous and heterologous viral proteinases. , 1995, European journal of biochemistry.

[10]  An engineered retroviral proteinase from myeloblastosis associated virus acquires pH dependence and substrate specificity of the HIV‐1 proteinase. , 1992, The EMBO journal.

[11]  M. Oswald,et al.  Fibronectin is a non‐viral substrate for the HIV proteinase , 1991, FEBS letters.

[12]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[13]  J. Louis,et al.  The effect of salt on the Michaelis Menten constant of the HIV‐1 protease correlates with the Hofmeister series , 1991, FEBS letters.

[14]  P. Štrop,et al.  Cloning, Bacterial Expression, and Characterization of the Mason-Pfizer Monkey Virus Proteinase (*) , 1995, The Journal of Biological Chemistry.

[15]  I. Pichová,et al.  The cleavage of host cell proteins by HIV-1 protease. , 1996, Folia biologica.

[16]  D. Cleveland,et al.  Intermediate filaments and their associated proteins: multiple dynamic personalities. , 1998, Current opinion in cell biology.

[17]  D. Ingber.  Tensegrity: the architectural basis of cellular mechanotransduction. , 1997, Annual review of physiology.

[18]  H. Gelderblom.  Assembly and morphology of HIV: potential effect of structure on viral function. , 1991, AIDS.

[19]  M J Bissell,et al.  Extracellular matrix signaling from the cellular membrane skeleton to the nuclear skeleton: a model of gene regulation. , 1996, Recent progress in hormone research.

[20]  R. Shoeman,et al.  Intermediate filament assembly and stability in vitro: effect and implications of the removal of head and tail domains of vimentin by the human immunodeficiency virus type 1 protease. , 1990, Cell biology international reports.

[21]  P. Traub,et al.  Species-specific recognition patterns of monoclonal antibodies directed against vimentin. , 1992, Experimental cell research.

[22]  B. Moss,et al.  HIV-1 protease cleaves actin during acute infection of human T-lymphocytes. , 1992, AIDS research and human retroviruses.

[23]  R. Shoeman,et al.  Intermediate filament proteins: cytoskeletal elements with gene-regulatory function? , 1994, International review of cytology.

[24]  I. Pichová,et al.  Three active forms of aspartic proteinase from Mason-Pfizer monkey virus. , 1998, Virology.

[25]  M. Wallin,et al.  Proteolytic cleavage of microtubule-associated proteins by retroviral proteinases. , 1990, The Journal of general virology.

[26]  I. Pichová,et al.  Potency comparison of peptidomimetic inhibitors against HIV-1 and HIV-2 proteinases: design of equipotent lead compounds. , 1997, Archives of biochemistry and biophysics.

[27]  W. Farmerie,et al.  Sensitive, soluble chromogenic substrates for HIV-1 proteinase. , 1990, The Journal of biological chemistry.

[28]  V. Kostka,et al.  Specificity studies on retroviral proteinase from myeloblastosis-associated virus. , 1991, Biochemistry.

[29]  T. Copeland,et al.  Solid phase synthesis of the proteinase of bovine leukemia virus Comparison of its specificity to that of HIV‐2 proteinase , 1992, FEBS letters.

[30]  J. Brynda,et al.  Processing, purification, and kinetic characterization of the Gag-Pol encoded retroviral proteinase of myeloblastosis associated virus expressed in E. coli. , 1995, Advances in experimental medicine and biology.

[31]  V. Beneš,et al.  Isolation, biochemical characterization and crystallization of the p15gag proteinase of myeloblastosis associated virus expressed in E. coli. , 1992, The International journal of biochemistry.

[32]  R. Luftig,et al.  Viral interactions with the host-cell cytoskeleton: the role of retroviral proteases. , 1994, Trends in microbiology.

[33]  K Weber,et al.  Intermediate filaments: structure, dynamics, function, and disease. , 1994, Annual review of biochemistry.

[34]  J. Konvalinka,et al.  An active-site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity , 1995, Journal of virology.

[35]  R. Shoeman,et al.  Potential role of the viral protease in human immunodeficiency virus type 1 associated pathogenesis. , 1992, Medical hypotheses.

[36]  P. Traub,et al.  Structural elements of the amino-terminal head domain of vimentin essential for intermediate filament formation in vivo and in vitro. , 1994, Experimental cell research.